Terms: = Lymphoma AND BUB1B, BUBR1, 701, ENSG00000156970, SSK1, BUB1beta, MAD3L, hBUBR1, Bub1A, O60566
91 results:
1. In vitro evaluation of Neosetophomone B inducing apoptosis in cutaneous T cell lymphoma by targeting the FOXM1 signaling pathway.
Kuttikrishnan S; Masoodi T; Ahmad F; Sher G; Prabhu KS; Mateo JM; Buddenkotte J; El-Elimat T; Oberlies NH; Pearce CJ; Bhat AA; Alali FQ; Steinhoff M; Uddin S
J Dermatol Sci; 2023 Nov; 112(2):83-91. PubMed ID: 37865581
[TBL] [Abstract] [Full Text] [Related]
2. In vivo lymph node CEST-Dixon MRI in breast cancer patients with metastatic lymph node involvement.
Donahue MJ; Donahue PMC; Jones RS; Garza M; Lee C; Patel NJ; Cooper A; De Vis JB; Meszoely I; Crescenzi R
Magn Reson Med; 2024 Feb; 91(2):670-680. PubMed ID: 37684712
[TBL] [Abstract] [Full Text] [Related]
3. Immunochemotherapy or chemotherapy alone in primary central nervous system lymphoma: a National Cancer Database analysis.
Ollila TA; Taher R; Moku P; Olszewski AJ
Blood Adv; 2023 Sep; 7(18):5470-5479. PubMed ID: 37459209
[TBL] [Abstract] [Full Text] [Related]
4. Cost-effectiveness analysis of imatinib versus dasatinib in the treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia when combined with conventional chemotherapy in China.
Chen M; Liu L; Zhang L; Lin Y; Lu X; Yang H; Ni J
BMC Health Serv Res; 2023 Jun; 23(1):652. PubMed ID: 37331932
[TBL] [Abstract] [Full Text] [Related]
5. Reproduction patterns among non-Hodgkin lymphoma survivors by subtype in Sweden, Denmark and Norway: A population-based matched cohort study.
Entrop JP; Weibull CE; Smedby KE; Jakobsen LH; Øvlisen AK; Glimelius I; Marklund A; Larsen TS; Holte H; Fosså A; Smeland KB; El-Galaly TC; Eloranta S
Br J Haematol; 2023 Aug; 202(4):785-795. PubMed ID: 37325886
[TBL] [Abstract] [Full Text] [Related]
6. Single-cell profiling of T cells uncovers a tissue-resident memory-like T-cell subset associated with bidirectional prognosis for B-cell acute lymphoblastic leukemia.
Lai W; Wang X; Liu L; Xu L; Mao L; Tan J; Zha X; Zhan H; Lei W; Lan Y; Chen G; Li Y; Luo OJ
Front Immunol; 2022; 13():957436. PubMed ID: 36532049
[TBL] [Abstract] [Full Text] [Related]
7. Higher doses of tisagenlecleucel are associated with improved outcomes: a report from the pediatric real-world CAR consortium.
Stefanski HE; Eaton A; Baggott C; Rossoff J; Verneris MR; Prabhu S; Pacenta HL; Phillips CL; Talano JA; Moskop A; Margossian SP; Myers GD; Karras NA; Brown PA; Qayed M; Hermiston M; Satwani P; Krupski MC; Keating AK; Wilcox R; Rabik CA; Fabrizio VA; Chinnabhandar V; Goksenin AY; Curran KJ; Mackall CL; Laetsch TW; Schultz LM
Blood Adv; 2023 Feb; 7(4):541-548. PubMed ID: 35938863
[TBL] [Abstract] [Full Text] [Related]
8. Enhancement of the International prognostic index with β2-microglobulin, platelet count and red blood cell distribution width: a new prognostic model for diffuse large B-cell lymphoma in the rituximab era.
Chen H; Zhong Q; Zhou Y; Qin Y; Yang J; Liu P; He X; Zhou S; Zhang C; Gui L; Yang S; Zhou L; Shi Y
BMC Cancer; 2022 May; 22(1):583. PubMed ID: 35624433
[TBL] [Abstract] [Full Text] [Related]
9. Pediatric T-ALL type-1 and type-2 relapses develop along distinct pathways of clonal evolution.
Richter-Pechańska P; Kunz JB; Rausch T; Erarslan-Uysal B; Bornhauser B; Frismantas V; Assenov Y; Zimmermann M; Happich M; von Knebel-Doeberitz C; von Neuhoff N; Köhler R; Stanulla M; Schrappe M; Cario G; Escherich G; Kirschner-Schwabe R; Eckert C; Avigad S; Pfister SM; Muckenthaler MU; Bourquin JP; Korbel JO; Kulozik AE
Leukemia; 2022 Jul; 36(7):1759-1768. PubMed ID: 35585141
[TBL] [Abstract] [Full Text] [Related]
10. Risk of Lymph Node Metastasis in T1b Gastric Cancer: An International Comprehensive Analysis from the Global Gastric Group (G3) Alliance.
Vos EL; Nakauchi M; Gönen M; Castellanos JA; Biondi A; Coit DG; Dikken JL; D'ugo D; Hartgrink H; Li P; Nishimura M; Schattner M; Song KY; Tang LH; Uyama I; Vardhana S; Verhoeven RHA; Wijnhoven BPL; Strong VE
Ann Surg; 2023 Feb; 277(2):e339-e345. PubMed ID: 34913904
[TBL] [Abstract] [Full Text] [Related]
11. Asparaginase enzyme activity levels and toxicity in childhood acute lymphoblastic leukemia: a NOPHO ALL2008 study.
Lynggaard LS; Rank CU; Hansen SN; Gottschalk Højfeldt S; Henriksen LT; Jarvis KB; Ranta S; Niinimäki R; Harila-Saari A; Wolthers BO; Frandsen TL; Heyman M; Schmiegelow K; Albertsen BK
Blood Adv; 2022 Jan; 6(1):138-147. PubMed ID: 34625787
[TBL] [Abstract] [Full Text] [Related]
12. External background ionizing radiation and childhood cancer: Update of a nationwide cohort analysis.
Mazzei-Abba A; Folly CL; Kreis C; Ammann RA; Adam C; Brack E; Egger M; Kuehni CE; Spycher BD
J Environ Radioact; 2021 Nov; 238-239():106734. PubMed ID: 34521026
[TBL] [Abstract] [Full Text] [Related]
13. 25-Hydroxy vitamin D deficiency predicts inferior prognosis in Hodgkin lymphoma.
Qin JQ; Yin H; Wu JZ; Chen RZ; Xia Y; Wang L; Zhu HY; Fan L; Li JY; Liang JH; Xu W
Leuk Res; 2021 Jun; 105():106580. PubMed ID: 33836479
[TBL] [Abstract] [Full Text] [Related]
14. IKZF1 Rs4132601 Polymorphism and Susceptibility to Acute Lymphocytic Leukemia in Children: A Meta-analysis.
Wu X; Liu M; Wang Q
J Pediatr Hematol Oncol; 2022 Jan; 44(1):e101-e108. PubMed ID: 33661176
[TBL] [Abstract] [Full Text] [Related]
15. Pre-existing antibodies against polyethylene glycol reduce asparaginase activities on first administration of pegylated E. coli asparaginase in children with acute lymphocytic leukemia.
Khalil A; Würthwein G; Golitsch J; Hempel G; Fobker M; Gerss J; Möricke A; Zimmermann M; Smisek P; Zucchetti M; Nath C; Attarbaschi A; Von Stackelberg A; Gökbuget N; Rizzari C; Conter V; Schrappe M; Boos J; Lanvers-Kaminsky C
Haematologica; 2022 Jan; 107(1):49-57. PubMed ID: 33299233
[TBL] [Abstract] [Full Text] [Related]
16. Caesarean sections, prenatal and postnatal conditions and childhood acute lymphoblastic leukaemia: A case-control study in the State of São Paulo, Brazil.
Junqueira MER; de Oliveira CT; Tone LG; Lee MLM; de Andréa MLM; Bruniera P; Epelman S; Odone Filho V; Bonilha EA; de Freitas M; Okamura MN; Vico ER; Stevens AP; Rabello Neto DL; Wünsch Filho V
Cancer Epidemiol; 2020 Dec; 69():101851. PubMed ID: 33186820
[TBL] [Abstract] [Full Text] [Related]
17. Malaria and risk of lymphoid neoplasms and other cancer: a nationwide population-based cohort study.
Wyss K; Granath F; Wångdahl A; Djärv T; Fored M; Naucler P; Färnert A
BMC Med; 2020 Oct; 18(1):296. PubMed ID: 33121475
[TBL] [Abstract] [Full Text] [Related]
18. Molecular heterogeneity of anti-PD-1/PD-L1 immunotherapy efficacy is correlated with tumor immune microenvironment in East Asian patients with non-small cell lung cancer.
Jin R; Liu C; Zheng S; Wang X; Feng X; Li H; Sun N; He J
Cancer Biol Med; 2020 Aug; 17(3):768-781. PubMed ID: 32944405
[No Abstract] [Full Text] [Related]
19. Discovery of Novel Agents on Spindle Assembly Checkpoint to Sensitize Vinorelbine-Induced Mitotic Cell Death Against Human Non-Small Cell Lung Cancers.
Chang YC; Tseng YL; Leu WJ; Du CM; Jiang YH; Hsu LC; Hsu JL; Hou DR; Guh JH
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32764382
[TBL] [Abstract] [Full Text] [Related]
20. MicroRNAs associated to single drug components of R-CHOP identifies diffuse large B-cell lymphoma patients with poor outcome and adds prognostic value to the international prognostic index.
Due H; Brøndum RF; Young KH; Bøgsted M; Dybkær K
BMC Cancer; 2020 Mar; 20(1):237. PubMed ID: 32192453
[TBL] [Abstract] [Full Text] [Related]
[Next]
